Veteran investment executive focused on growth-stage healthcare and tech opportunities, with operating experience in corporate strategy and M&A. Melissa Imbrogno brings experience across private equity, corporate development and portfolio company leadership, often leading due diligence, operational improvement programs and capital raises. Market-facing profile: active deal leader, board observer and strategic operator supporting scaling and exits.
Veteran investment executive focused on growth-stage healthcare and tech opportunities, with operating experience in corporate strategy and M&A. Melissa Imbrogno brings experience across private equity, corporate development and portfolio company leadership, often leading due diligence, operational improvement programs and capital raises. Market-facing profile: active deal leader, board observer and strategic operator supporting scaling and exits.
Focuses on growth-stage healthcare and technology companies where operational intervention accelerates scale and exit value. Prefers equity-led primers and control/minority positions that enable active board or operator influence, prioritizing durable revenue models, differentiated clinical or tech moats, and capital-efficient commercialization pathways. Investment cadence balances rigorous due diligence, hands-on post-close operational improvement and targeted follow-on capital to de-risk milestones over a 3–7 year horizon with disciplined downside protection and exit orientation.
Focuses on growth-stage healthcare and technology companies where operational intervention accelerates scale and exit value. Prefers equity-led primers and control/minority positions that enable active board or operator influence, prioritizing durable revenue models, differentiated clinical or tech moats, and capital-efficient commercialization pathways. Investment cadence balances rigorous due diligence, hands-on post-close operational improvement and targeted follow-on capital to de-risk milestones over a 3–7 year horizon with disciplined downside protection and exit orientation.
| Trades 1142 | Longs Won 835/1142 73% | Profit Factor 10.92 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $390,819.34 |
| Average Win $125,643.71 | Best Trade (Oct 16) $6.06M | Sharpe Ratio -72.36 |
| Average Loss -$31,293.51 | Worst Trade (Oct 14) -$368,995.52 | Z-Score 11.49 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 2w 3d | Expectancy $83,551.3 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 14,286 | 12,857 | 11,429 | 10,000 | 8,571 | 7,143 | 5,714 | 4,286 | 2,857 | 1,429 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAOI Applied Optoelectronics, Inc. | 3,505 | $296,488.08 | $285,026.6 | - | -$11,461.48 | -3.87% | -2.878% |
AAPL Apple Inc. | 19,963 | $4.51M | $6.86M | - | $2.34M | 51.95% | +0.409% |
ABBV AbbVie Inc. | 1,722 | $370,152.3 | $487,635.96 | - | $117,483.66 | 31.74% | -0.078% |
ACEI Innovator Equity Accelerated Income Strategy ETF | 14,488 | $335,336 | $345,249.04 | - | $9,913.04 | 2.96% | 0.0 |
ACII Innovator Index Autocallable Income ETF | 13,925 | $354,391 | $355,087.5 | - | $696.5 | 0.2% | +0.473% |
AIQ Global X Artificial Intelligence & Technology ETF | 99,007 | $5.41M | $6.29M | - | $885,024.35 | 16.36% | -0.796% |
ALT Altimmune, Inc. | 236,136 | $1.17M | $543,112.8 | - | -$621,911.23 | -53.38% | -2.542% |
AMAT Applied Materials, Inc. | 428 | $309,444 | $182,477.8 | - | -$126,966.2 | -41.03% | -0.851% |
AMD Advanced Micro Devices, Inc. | 1,266 | $267,435.29 | $693,090.69 | - | $425,655.4 | 159.16% | -2.626% |
AMZN Amazon.com Inc | 8,557 | $1.51M | $2.17M | - | $652,945.41 | 43.12% | -0.591% |
AVGO Broadcom Inc. | 2,993 | $849,950.15 | $1.01M | - | $164,497.27 | 19.35% | -1.565% |
BALT Inn Defined Wealth Shield Mutual Fund | 155,832 | $4.88M | $5.46M | - | $580,963.5 | 11.9% | +0.014% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 388,428 | $29.82M | $28.55M | - | -$1.27M | -4.26% | -0.061% |
BNDX Vanguard Total International Bond ETF | 148,195 | $7.16M | $6.99M | - | -$170,762.85 | -2.39% | -0.117% |
BRBR BellRing Brands Inc. | 14,128 | $159,222.56 | $127,293.28 | - | -$31,929.28 | -20.05% | +0.222% |
BRK-B Berkshire Hathaway Inc. | 1,128 | $562,754.37 | $598,753.68 | - | $35,999.31 | 6.4% | +0.976% |
CAIE Calamos Autocallable Income ETF | 7,813 | $208,789.09 | $208,828.99 | - | $39.9 | 0.02% | -0.081% |
CAT Caterpillar Inc. | 454 | $235,782.64 | $336,827.14 | - | $101,044.5 | 42.85% | +0.852% |
CHAT Roundhill Generative AI & Technology ETF | 4,270 | $261,556.74 | $347,620.7 | - | $86,063.96 | 32.9% | -2.257% |
CIFR Cipher Mining Inc. | 8,536 | $209,132 | $84,378.36 | - | -$124,753.64 | -59.65% | -1.544% |